Tuesday, March 13, 2007
Noven Receives $25 Million Daytrana(TM) Sales Milestone
Genetic Engineering News - Daytrana(TM), developed and manufactured by Noven, is the first and only transdermal medication before using Daytrana(TM) if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar
Source: www.genengnews.com
Click here for more information about beck depression inventory beck depression inventory